Patents by Inventor Henrik Everberg

Henrik Everberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prostate kallikrein allergen
    Patent number: 9518987
    Abstract: Methods for treatment of a Type I allergy in a mammal comprise administering to an individual in need of such treatment a polypeptide of SEQ ID NO: 1 or the mature protein, amino acids 25-260, of the polypeptide of SEQ ID NO: 1, or a fragment of the polypeptide or the mature protein, which fragment shares epitopes for antibodies with the polypeptide or the mature protein, respectively, or a hypoallergenic form thereof that is modified to abrogate or attenuate its IgE binding response. Diagnostic kits comprise the polypeptide of SEQ ID NO: 1 or the mature protein, amino acids 25-260, of the polypeptide of SEQ ID NO: 1, immobilized on a solid support.
    Type: Grant
    Filed: November 3, 2015
    Date of Patent: December 13, 2016
    Assignee: PHADIA AB
    Inventors: Lars Mattsson, Jonas Lidholm, Henrik Everberg
  • Prostate kallikrein allergen
    Patent number: 9274114
    Abstract: Methods for in vitro diagnosis of type I allergy comprises the steps of contacting an immunoglobulin-containing body fluid sample from a patient suspected of having type I allergy with a variant or fragment of the mature protein, amino acids 25-260, of the polypeptide of SEQ ID NO: 1, which variant or fragment shares epitopes for antibodies with the mature protein, amino acids 25-260, of the polypeptide of SEQ ID NO: 1; and detecting the presence, in the sample, of IgE antibodies specifically binding to the variant or fragment. The presence of such IgE antibodies specifically binding to the variant or fragment is indicative of a type I allergy in the patient.
    Type: Grant
    Filed: May 13, 2014
    Date of Patent: March 1, 2016
    Assignee: Phadia AB
    Inventors: Lars Mattsson, Jonas Lidholm, Henrik Everberg
  • Novel Prostate Kallikrein Allergen
    Publication number: 20160051666
    Abstract: Methods for treatment of a Type I allergy in a mammal comprise administering to an individual in need of such treatment a polypeptide of SEQ ID NO: 1 or the mature protein, amino acids 25-260, of the polypeptide of SEQ ID NO: 1, or a fragment of the polypeptide or the mature protein, which fragment shares epitopes for antibodies with the polypeptide or the mature protein, respectively, or a hypoallergenic form thereof that is modified to abrogate or attenuate its IgE binding response. Diagnostic kits comprise the polypeptide of SEQ ID NO: 1 or the mature protein, amino acids 25-260, of the polypeptide of SEQ ID NO: 1, immobilized on a solid support.
    Type: Application
    Filed: November 3, 2015
    Publication date: February 25, 2016
    Inventors: Lars Mattsson, Jonas Lidholm, Henrik Everberg
  • Prostate kallikrein allergen
    Patent number: 9182400
    Abstract: Prostatic kallikrein for the manufacture of a diagnostic or pharmaceutical composition for diagnosis/treatment of type 1 allergy, especially allergy to dogs.
    Type: Grant
    Filed: December 21, 2007
    Date of Patent: November 10, 2015
    Assignee: PHADIA AB
    Inventors: Lars Mattsson, Jonas Lidholm, Henrik Everberg
  • Novel Prostate Kallikrein Allergen
    Publication number: 20140249048
    Abstract: Methods for in vitro diagnosis of type I allergy comprises the steps of contacting an immunoglobulin-containing body fluid sample from a patient suspected of having type I allergy with a variant or fragment of the mature protein, amino acids 25-260, of the polypeptide of SEQ ID NO: 1, which variant or fragment shares epitopes for antibodies with the mature protein, amino acids 25-260, of the polypeptide of SEQ ID NO: 1; and detecting the presence, in the sample, of IgE antibodies specifically binding to the variant or fragment. The presence of such IgE antibodies specifically binding to the variant or fragment is indicative of a type I allergy in the patient.
    Type: Application
    Filed: May 13, 2014
    Publication date: September 4, 2014
    Applicant: Phadia AB
    Inventors: Lars Mattsson, Jonas Lidholm, Henrik Everberg
  • Novel Prostate Kallikrein Allergen
    Publication number: 20100129409
    Abstract: Prostatic kallikrein for the manufacture of a diagnostic or pharmaceutical composition for diagnosis/treatment of type 1 allergy, especially allergy to dogs.
    Type: Application
    Filed: December 21, 2007
    Publication date: May 27, 2010
    Inventors: Lars Mattsson, Jonas Lidholm, Henrik Everberg